Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stockholm - Delayed Quote SEK

Sedana Medical AB (publ) (SEDANA.ST)

10.34
+0.24
+(2.38%)
At close: April 25 at 5:29:49 PM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
NameTitlePayExercisedYear Born
Mr. Johannes Doll CEO & President 6.57M -- 1981
Mr. Johan G. Spetz Chief Financial Officer -- -- 1984
Ms. Karolina Vilval L.L.M. General Counsel -- -- 1979
Mr. Peter Sackey M.D., Ph.D. Chief Medical Officer -- -- 1971
Ms. Linda Frölén Head of Group Finance -- -- --
Anders Ersson Head of International Markets -- -- 1969
Mr. Jessica Westfal VP of Regulatory Affairs and QA -- -- 1974
Mr. Uwe Veismann General Manager of Germany, Nordics & Benelux -- -- 1981
Mr. Stefan Krisch Supply Chain & Manufacturing Director -- -- 1974

Sedana Medical AB (publ)

Svärdvägen 3A
Danderyd, 182 33
Sweden
46 8 12 40 52 00 https://www.sedanamedical.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
125

Description

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the administration of inhaled anaesthetics. It also provides FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; scavenging tube, a one-piece pre-connected tube designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; FlurAbsorb mount to hold the FlurAbsorb during scavenging of anaesthetic gas; FlurAbsorb-S mount to hold the FlurAbsorb-S during scavenging of anaesthetic gas; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to FlurAbsorb/FlurAbsorb-S; and Mindray exhaust connector, which enables connection of the exhaust of the ventilator to an active or passive scavenging system. In addition, the company offers AMG-06 Gas Monitor for continuous non-invasive sidestream monitoring of CO2 and anaesthetics concentration in inspired and expired gases; Sedaconda Filling Adapter, a single-use device for safe and easy extraction of isoflurane from a Sedaconda bottle to a Sedaconda Syringe; and a single-use standard iso/sevo adapter that is designed to fit standard threaded isoflurane and sevoflurane bottles. Further, it provides DRYLINE II and WaterLock 2 water traps, Nafion dryer tubing, respiratory gas monitoring lines, and gas sampling line H products. The company was founded in 1999 and is headquartered in Danderyd, Sweden.

Corporate Governance

Sedana Medical AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 6, 2025 at 5:00 AM UTC

Sedana Medical AB (publ) Earnings Date

Recent Events

Related Tickers